Attempting to Maintain Normoglycemia During Cardiopulmonary Bypass with Insulin May Initiate Postoperative Hypoglycemia
- 1 November 1999
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 89 (5) , 1091-1095
- https://doi.org/10.1213/00000539-199911000-00004
Abstract
We attempted to develop an insulin administration protocol that maintains normoglycemia in patients undergoing cardiac surgery and to study the effects of intraoperative blood glucose management on serum levels of creatine phosphokinase isoenzyme BB (CK-BB) and S-100 protein. Twenty nondiabetic patients were randomly allocated to receive either "tight control" of blood glucose with a standardized IV insulin infusion intraoperatively (Group TC) or "no control" of blood glucose intraoperatively (Group NC). Perioperative serum levels of glucose, CK-BB, and S-100 protein were determined in all patients. Group TC patients received 90.0 +/- 49.2 units of insulin, whereas Group NC patients received none. Despite insulin, both Group TC (P = 0.00026) and Group NC (P = 0.00003) experienced similar significant increases in blood glucose levels during hypothermic cardiopulmonary bypass. However, mean blood glucose level upon intensive care unit arrival was significantly decreased in Group TC, compared with Group NC (84.7 +/- 41.0 mg/dL, range 32-137 mg/dL vs 201.4 +/- 67.5 mg/dL, range 82-277 mg/dL, respectively; P = 0.0002). Forty percent of Group TC patients required treatment for postoperative hypoglycemia (blood glucose level <60 mg/dL). Substantial interindividual variability existed in regard to insulin resistance. The investigation was terminated after we realized that normoglycemia was unattainable with the study protocol and that postoperative hypoglycemia was unpredictable. All patients in both groups experienced similar significant increases in postoperative serum levels of CK-BB and S-100 protein. These results indicate that "tight control" of intraoperative blood glucose in nondiabetic patients undergoing cardiac surgery was unattainable with the study protocol and may initiate postoperative hypoglycemia. The appropriate intraoperative management of hyperglycemia and whether it adversely affects neurologic outcome in patients after cardiac surgery remains controversial. This investigation reveals that attempting to maintain normoglycemia in this setting with insulin may initiate postoperative hypoglycemia.Keywords
This publication has 16 references indexed in Scilit:
- Markers of cerebral ischemia after cardiac surgeryJournal of Cardiothoracic and Vascular Anesthesia, 1996
- Neuropsychologic change after cardiac surgery: A critical reviewJournal of Cardiothoracic and Vascular Anesthesia, 1996
- Serum S100 protein: A potential marker for cerebral events during cardiopulmonary bypassThe Annals of Thoracic Surgery, 1996
- Pro: Glucose priming solutions should be used for cardiopulmonary bypassJournal of Cardiothoracic and Vascular Anesthesia, 1995
- Con: Glucose priming solutions should not be used for cardiopulmonary bypassJournal of Cardiothoracic and Vascular Anesthesia, 1995
- Hyperglycemia during Hypothermic Canine Cardiopulmonary Bypass Increases Cerebral LactateAnesthesiology, 1995
- Special issuesCritical Care Medicine, 1992
- Neuropsychological dysfunction after cardiopulmonary bypass: A comparison of two institutionsJournal of Cardiothoracic and Vascular Anesthesia, 1991
- Benefits of a Glucose-Containing Priming Solution for Cardiopulmonary BypassAnesthesia & Analgesia, 1991
- Glucose Management During Cardiopulmonary BypassAnesthesia & Analgesia, 1991